O fator de impacto mede o número médio de citações recebidas em um ano por trabalhos publicados na revista durante os dois anos anteriores.
© Clarivate Analytics, Journal Citation Reports 2025
Informação da revista
Os mais lidos
3512
Lymphoma-associated hemophagocytic lymphohistiocytosisThomás de Souza Patto Marcondes, Carlos Sérgio Chiattone, Rafael Dezen Gaiolla
Hematol Transfus Cell Ther. 2026;48:106087
3512
Acesso de texto completo
1133
Evaluation of the effects of fucoidan extracted from sargassum angustifolium on coagulation factors and biochemical parameters in male Wistar ratsAsma Dehghani, Ameneh Khoshvaghti, Narges Obeidi
Hematol Transfus Cell Ther. 2026;48:106073
1133
Acesso de texto completo
1061
Outcomes after bone marrow versus peripheral blood haploidentical hematopoietic cell transplantation using post-transplant cyclophosphamide-based graft-versus-host disease prophylaxisMuhammad Kashif Amin, Moazzam Shahzad, Abat Khan, Valiko Begiashvili, Ushna Khan, Matthew McGuirk, Shaun DeJarnette, Sibgha Gull Chaudhary, ... Muhammad Umair Mushtaq
Hematol Transfus Cell Ther. 2026;48:106222
1061
Acesso de texto completo
1047
In patients with suspected thrombotic thrombocytopenic purpura, what is the optimal time to therapeutic plasma exchange?Alexandre Soares Ferreira Junior, Kate Sanborn, Morgana Pinheiro Maux Lessa, Alexander Gordee, Maragatha Kuchibhatla, Allison O. Taylor, Matthew S. Karafin, Oluwatoyosi A. Onwuemene
Hematol Transfus Cell Ther. 2026;48:106223
1047
Acesso de texto completo
1000
Identification of an in-frame insertion in ACKR1 in five individuals from Agri community, IndiaShaikh Roshan, Solanki Prakash, Ghosh Kanjaksha, Gorakshakar Ajit
Hematol Transfus Cell Ther. 2026;48:106075
1000
Acesso de texto completo
932
Changes in the microbiota following allogeneic hematopoietic stem cell transplantation: A potential bioguide for clinical outcome?Ekin Ece Gurer-Kluge, Fatma Savran Oguz, Zerrin Aktas, Sevgi Kalayoglu Besisik, Ugur Sezerman, Oral Oncul, Zafer Gulbas
Hematol Transfus Cell Ther. 2026;48:106074
932
Acesso de texto completo
842
Obstetrical use of intravenous immunoglobulin: A single-centre retrospective studyRoy Khalife, Bonnie Niu, Iris Perelman, Darine El-Chaâr, Dean Fergusson, Alan Karovitch, Johnathan Mack, Melanie Tokessy, ... Alan Tinmouth
Hematol Transfus Cell Ther. 2026;48:106225
842
Acesso de texto completo
832
Integrating comprehensive care in the management of sickle cell disease patients in NigeriaEfobi Chilota Chibuife, Nri-Ezedi Chisom Adaobi, Chilaka Ugochinyere Jenny, Okoye Helen Chioma, Anigbogu Ikechukwu Okwudili, Okwummuo Emeka Paul, Ogundeji Sunday Peter, Eze Onyinye Ezinne
Hematol Transfus Cell Ther. 2026;48:106091
832
Acesso de texto completo
797
Cold-stored platelets: A systematic review of recovery in healthy adults and chest drain output in cardiothoracic surgery patientsCaleb Keane, Heba Sharif, Denise Jackson
Hematol Transfus Cell Ther. 2026;48:106226
797
Acesso de texto completo
792
Hereditary thrombocytopenias: the challenge of increasing frequency and differential diagnosisRafiye Çiftçiler
Hematol Transfus Cell Ther. 2026;48:106076
792
Acesso de texto completo
750
Assessment of the neutrophil-to-lymphocyte ratio as a prognostic marker in patients with newly diagnosed diffuse large B-cell lymphoma: A Colombian Cohort StudyPaula María Sánchez, Juan Felipe Combariza-Vallejo
Hematol Transfus Cell Ther. 2026;48:106237
750
Acesso de texto completo
646
First report of perioperative iptacopan interruption in paroxysmal nocturnal hemoglobinuria without breakthrough hemolysisKatsuhiro Tokuda, Tatsuki Morioka, Shoya Arai, Takuji Matsuo, Kensuke Matsumoto, Ryosuke Shirasaki, Jun Ooi, Haruko Tashiro
Hematol Transfus Cell Ther. 2026;48:106235
646
Acesso de texto completo
584
Efficacy and safety analysis of the use of ibrutinib associated with rituximab for the first-line treatment of patients with chronic lymphocytic leukaemiaAline do Nascimento, Daniel da Silva Pereira Curado, Thais Montezuma, Wallace Breno Barbosa, Juliana Machado-Rugolo, Mariana Millan Fachi
Hematol Transfus Cell Ther. 2026;48:106234
584
Acesso de texto completo
575
Mechanistic insights into the antiproliferative effect of the redox-active iron chelator Dp44mT on multiple myeloma cell linesAarti Sharma, Latha Pathangey, Sinto Sebastian Chirackal, Kiran K. Mangalaparthi, Akhilesh Pandey, Rafael Fonseca, Sundararaman Swaminathan
Hematol Transfus Cell Ther. 2026;48:106233
575
Acesso de texto completo
556
Platelet transfusion in end-of-life adult careDiana Cibele, Fernanda Trigo, Miguel Barbosa, Jorge Almeida, José Artur Paiva, Edna Gonçalves, João Brito, José Teixeira, Fernando Araújo
Hematol Transfus Cell Ther. 2026;48:106228
556
Acesso de texto completo
533
Mesenchymal stromal cells secretory pattern contributes to oncoinflammatory bone marrow microenvironment in polycythemia veraJuçara Gastaldi Cominal, Maira da Costa Cacemiro, Giovana Michelassi Berbel, Rifkath Marie Laurance Rahimy, Gisele Vieira Rocha, Dalila Lucíola Zanette, Maria Carolina Oliveira, Lorena Lobo de Figueiredo-Pontes, ... Fabíola Attié de Castro
Hematol Transfus Cell Ther. 2026;48:106224
533
Acesso de texto completo
466
Beyond the crisis: Tracking chronic neuropathic pain in sickle cell disease using Douleur Neuropathique 4 and PainDETECT questionnairesCamila Freitas de Andrade Rodrigues, Thiago Alves Rodrigues, Pedro Igor de Sousa Rios, Isabelle Nunes Costa, Bruno Feres de Souza, João Batista Santos Garcia
Hematol Transfus Cell Ther. 2026;48:106231
466
Acesso de texto completo
441
National multiple myeloma cohort: Gaps and opportunities for research in BrazilDiogo Moreira do Amaral
Hematol Transfus Cell Ther. 2026;48:106229
441
Acesso de texto completo
437
Plasma levels of soluble podoplanin are higher in acute promyelocytic leukemia compared to other forms of acute myeloid leukemiaCarla Roberta Peachazepi Moraes, Camilla Maria de Alencar Saraiva, Ivanio Teixeira Borba-Junior, Bruno Kosa Lino Duarte, Paula Melo de Campos, Sara Teresinha Olalla Saad, Erich Vinicius De Paula
Hematol Transfus Cell Ther. 2026;48:106227
437
Acesso de texto completo




